Growth Metrics

Bioventus (BVS) Change in Cash (2020 - 2026)

Bioventus filings provide 6 years of Change in Cash readings, the most recent being $9.1 million for Q4 2025.

  • On a quarterly basis, Change in Cash rose 708.18% to $9.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.7 million, a 109.09% increase, with the full-year FY2025 number at $9.7 million, up 109.09% from a year prior.
  • Change in Cash hit $9.1 million in Q4 2025 for Bioventus, down from $9.3 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $42.6 million in Q2 2021 to a low of -$41.7 million in Q3 2022.
  • Median Change in Cash over the past 5 years was -$2.0 million (2022), compared with a mean of -$1.8 million.
  • Biggest five-year swings in Change in Cash: plummeted 583.55% in 2022 and later soared 708.18% in 2025.
  • Bioventus' Change in Cash stood at -$31.7 million in 2021, then soared by 91.97% to -$2.5 million in 2022, then surged by 498.31% to $10.1 million in 2023, then tumbled by 114.72% to -$1.5 million in 2024, then soared by 708.18% to $9.1 million in 2025.
  • The last three reported values for Change in Cash were $9.1 million (Q4 2025), $9.3 million (Q3 2025), and $10.1 million (Q2 2025) per Business Quant data.